Ledesma-Heyer JP, Valdés-Escárcega M, Ramos-Ostos MH

Language: Spanish
References: 46
Page: 168-173
PDF size: 81.29 Kb.

ABSTRACT

Immunosenescence is an idiopathic form of acquired immunodeficiency as a result of molecular and cellular changes common in older people. This article will review the major changes in thymus and innate/acquired immune response. We also discuss some immune theories of aging. Various diseases typical in elderly (infections, cancer, chronic and degenerative diseases, osteoporosis, etc.) have their roots in an aged immune system.

REFERENCES

1. Fillit H. Clinical immunology of aging. Rev Clin Gerontol 1994; 4: 187-97.

2. Iglesias M. Inmunosenescencia y autoinmunidad. Reumatología 2003; 19(2): 61-7.

3. Burkle A, Caselli G, Franceschi C, et al. Pathophysiology of ageing, longevity and age related diseases. Immun Ageing 2007; 4: 4.

4. Ginaldi L, Mengoli LP, DeMartinis M. Review on immunosenescence. Rev Clin Gerontol 2007; 17: 161-9.

5. Rider D, Young S. A radical view of immunosenescence: Does chronic redox depletion interfere with immune cell signaling and function? Rev Clin Gerontol 2000; 10: 5-15.

6. Yu BP, Chung HY. The inflammatory process in aging. Rev Clin Gerontol 2006; 16: 179-87.

7. Vasto S, Malavolta M, Pawelec G. Age and immunity. Immun Ageing 2006; 3: 2.

8. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 2006; 24: 491-6.

9. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8.

10. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-aging and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS 2005; 579: 2035-9.

11. Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity, ageing and cancer. Immun Ageing 2008; 5: 11.

12. Boren E, Gershwin E. Inflamm-ageing: autoimmunity, and the immune-risk phenotype. Autoimmunity Reviews 2004; 3: 401-6.

13. Remarque E, Pawelec G. T-cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol 1998; 8: 5-14.

14. Chung HY, Kim HJ, Jung KJ, et al. The inflammatory process in aging. Rev Clin Gerontol 2000; 10: 207-22.

15. Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000; 3: 455-73.

16. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5(2): 133-9.

17. Tortorella C, Pisconti A, Piazolla G, Antonaci S. APC-dependent impairment of T-cell proliferation in aging:role of the CD28-and IL-12/15 medicated signaling. Mech Ageing Dev 2002; 123: 1389-402.

18. Effros R. Roy Walford and the immunologic theory of aging. Immun Ageing 2005; 2: 7.

19. Kennes B, Hubert C, Brohee D, Neve P. Early biochemical events associated with lymphocyte activation in aging. I. Evidence that Ca2+-dependent processes induced by PHA are impaired. Immunology 1981; 42: 119-26.

20. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-72.

21. Giradon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients. A randomized controlled trial. Arch Intern Med 1999; 159: 748-54.

22. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007; 128: 83-91.

23. Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immun 2008; 9(5): 503-10.

24. Hadrup SR, Kollgard T, Saremet T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006; 176: 2645-53.

25. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80: 219-27.

26. Bruunsgaard H, Andersen-Ramberg K, Jeune B, et al. A high plasma concentration of TNF-á is associated with dementia in centenarians. J Gerontol 1999; 54: 357-64.

27. Pawelec G, Larbi A. Immunity and ageing in man: Annual Review 2006/2007. Exp Gerontol 2008; 43: 34-8.

28. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of fas (CD95), fas ligand, bcl- 2, and bax. J Immunol 1998; 160: 1627-37.

29. LeMaoult J, Szabo P, Weksler ME. Effect of age on humoral immunity, selection of the B-cell repertoire and b-cell development. Immunol Rev 1997; 160: 115-26.

30. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.

31. Aukrust P, Svardal AM, Muller F, et al. Increased levels of oxidized glutathione in CD4(+) lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type-1 infection. Blood 1995; 86: 258-67.

32. Hanson PM. Dampening inflammation. Nat Immunol 2005; 6: 1189-81.

33. Yu BP, Yang R. Critical evaluation of free radical theory of aging: a proposal of oxidative stress hypothesis. Ann NY Acad Sci 1996; 786: 1-11.

34. Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003; 2: 457-61.

35. Licastro F, Grimaldi LME, Bonafe M, et al. Interleukin-6 gene alleles affect the risk of Alzheimer´s disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003; 24: 921-6.

36. Hayden M, Ghosh S. Shared principles in NK-kB signaling. Cell 2008; 132: 344-62.

37. Poon HF, Calabrese V, Scapagnini G, Butterfield A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 2004; 59(5): 478-93.

38. Zingarelli B. Nuclear factor-kB. Crit Care Med 2005; 33(12): S414-S416.

39. Gupta S. Tumor necrosis factor-A-induced apoptosis in T cells from aged humans; a role of TNFR-I and downstream signaling molecules. Exp Gerontol 2002; 37: 293-99.

40. Kim HJ, Jung KJ, Yu BP, et al. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech Ageing Dev 2002; 123: 1589-95.

41. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Rad Biol Med 1996; 21: 651-68.

42. Sung BK, Park S, Yu BP, Chung HY. Amelioration of age-related inflammation and oxidative stress by PPARγ activator: suppression of NF-κΒ by 2,4-thiazolidinedione. Exp Geront 2006; 41: 590-9.

43. Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005; 60: 556-65.

44. Henson SM, Snelgrove R, Hussell T, et al. An IL-7 fusion protein that shows increased thymopoietic ability. J Immunol 2005; 15(175): 4112-8.

45. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000; 18: 1613-20.

46. Ginaldi L, De Martinis M, Modesti M, et al. Immunophenotypical changes of T lymphocytes in the elderly. Gerontology 2000; 46: 242-8.